Not Your Mother’s Dopamine Agonist: Tavapadon

27 Oct 2026 0 comments

Neurologists Kathrin LaFaver and Zoltan Mari discuss tavapadon, the recently FDA-approved drug for Parkinson’s disease. Is it best for de novo patients or in fluctuating patients with OFF time?
Medscape Neurology

Source: Medscape Neurology Published 27 Oct 2026 Imported 27 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment